The ergosterol biosynthesis pathway, transporter genes, and azole resistance in Aspergillus fumigatus

References

• Denning DW. Diagnosis and management of invasive aspergillosis. Curr Clin Top Infect Dis 1996; 16: 277–299
   PubMedGoogle Scholar
• Herbrecht R, Denning D, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408–415
   PubMed Web of Science ®Google Scholar
• Denning DW, Venkateswarlu K, Oakley KL, et al. Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 1997; 41: 1364–1368
   PubMed Web of Science ®Google Scholar
• Dannaoui E, Borel E, Monier MF, et al. Acquired itraconazole resistance in Aspergillus fumigatus. J Antimicrob Chemother 2001; 47: 333–340
   PubMed Web of Science ®Google Scholar
• Manavathu EK, Vazquez JA, Chandrasekar PA. Reduced susceptibility in laboratory-selected mutants of Aspergillus fumigatus to itraconazole due to decreased intracellular accumulation of the antifungal agent. Int J Antimicrob Agents 1999; 12: 213–219
   PubMedGoogle Scholar
• Mann PA, Parmegiani RM, Wei S-Q, et al. Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P-450 14α-demethylase. Antimicrob Agents Chemother 2003; 47: 577–581
   PubMed Web of Science ®Google Scholar
• Manavathu EK, Alangaden GJ, Chandrasekar PH. In vitro isolation and antifungal susceptibility of amphotericin B-resistant mutants of Aspergillus fumigatus. J Antimicrob Chemother 1998; 41: 615–619
   PubMed Web of Science ®Google Scholar
• Dannaoui E, Persat F, Borel E, Piens M-A, Picot S. Sterol composition of itraconazole-resistant and itraconazole-susceptible isolates of Aspergillus nidulans. Can J Microbiol 2001; 47: 706–710
   Google Scholar
• Mosquera J, Denning DW. Azole cross-resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 2002; 46: 556–557
   PubMed Web of Science ®Google Scholar
• Manavathu EK, Abraham OC, Chandrasekar PH. Isolation and in vitro susceptibility to amphotericin B, itraconazole and posaconazole of voriconazole-resistant laboratory isolates of Aspergillus fumigatus. Clin Microbiol Infect 2001; 7: 130–137
   PubMed Web of Science ®Google Scholar
• Dannaoui E, Meletiadis J, Tortorano A-M, et al. Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patients. J Med Microbiol 2004; 53: 129–134
   PubMed Web of Science ®Google Scholar
• Kontoyiannis DP, Lewis RE, Lionakis MS, et al. Sequential exposure of Aspergillus fumigatus to itraconazole and caspofungin: evidence of enhanced in vitro activity. Diagn Microbiol Infect Dis 2003; 47: 415–419
   PubMed Web of Science ®Google Scholar
• Liu W, Lionakis MS, Lewis RE, et al. Attenuation of itraconazole fungicidal activity following pre-exposure of Aspergillus fumigatus to fluconazole. Antimicrob Agents Chemother 2003; 47: 3592–3597
   Google Scholar
• Mellado E, Diaz-Guerra TM, Cuenca-Estrella M, Rodríguez-Tudela JL. Identification of two different 14-alpha sterol demethylase-related genes (cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus species. J Clin Microbiol 2001; 39: 2431–2438
   PubMed Web of Science ®Google Scholar
• Diaz-Guerra TM, Mellado E, Cuenca-Estrella M, Rodríguez-Tudela JL. A point mutation in the 14α-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 2003; 47: 1120–1124
   PubMed Web of Science ®Google Scholar
• Marichal P, Koymas L, Willlemsens S, et al. Contribution of mutations in the cytochrome P-450 14-α-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology 1999; 145: 2701–2713
   PubMed Web of Science ®Google Scholar
• Sanglard D, Odds FC. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2002; 2: 73–85
   PubMed Web of Science ®Google Scholar
• White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 1998; 11: 382–402
   PubMed Web of Science ®Google Scholar
• Lupetti A, Danesi R, Campa M, del Tacca M, Kelly S. Molecular basis of resistance to azole antifungals. Trends Mol Med 2002; 8: 76–81
   PubMed Web of Science ®Google Scholar
• Sanglard D, Ischer F, Parkinson T, Falconer D, Bille J. Candida albicans: mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents. Antimicrob Agents Chemother 2003; 47: 2404–2412
   PubMed Web of Science ®Google Scholar
• Kelly SL, Lamb DC, Kelly DE, Loeffler J, Einsele H. Resistance to fluconazole and amphotericin in Candida albicans from AIDS patients. Lancet 1996; 348: 1523–1524
   PubMed Web of Science ®Google Scholar
• Kelly SL, Lamb DC, Kelly DE, et al. Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol delta 5,6-desaturation. FEBS Lett 1997; 400: 80–82
   PubMed Web of Science ®Google Scholar
• Nolte FS, Parkinson T, Falconer DJ, et al. Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukaemia. Antimicrob Agents Chemother 1997; 44: 196–199
   Google Scholar
• Xiao L, Madison V, Chau AS, et al. Three-dimensional models of wild-type and mutated forms of cytochrome P450 14α-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding. Antimicrob Agents Chemother 2004; 48: 568–574
   PubMed Web of Science ®Google Scholar
• Osherov N, Kontoyannis DP, Romans A, May GS. Resistance to itraconazole in Aspergillus nidulans and Aspergillus fumigatus is conferred by extra copies of the A. nidulans P-450 14α-demethylase gene, pdmA. J Antimicrob Chemother 2001; 48: 75–81
   PubMed Web of Science ®Google Scholar
• Tobin MB, Peery RB, Skatrud PL. Genes encoding multiple drug resistance-like proteins in Aspergillus fumigatus and Aspergillus flavus. Gene 1997; 200: 11–23
   Google Scholar
• Slaven JW, Anderson MJ, Sanglard D, et al. Increased expression of a novel Aspergillus fumigatus ABC transporter gene, AtrF, in the presence of itraconazole in an itraconazole resistant clinical isolate. Fungal Genetics Biol 2002; 36: 199–206
   PubMed Web of Science ®Google Scholar
• Nascimento AM, Goldman GH, Park S, et al. Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole. Antimicrob Agents Chemother 2003; 47: 1519–1526
   Google Scholar
• Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997; 25: 4876–4882
   PubMed Web of Science ®Google Scholar
• Moore CB, Sayers N, Mosquera J, Slaven J, Denning DW. Antifungal drug resistance in Aspergillus. J Infect 2000; 41: 203–220
   PubMed Web of Science ®Google Scholar
• Chandrasekar, PH. Are susceptibility patterns for Aspergillus changing? Advances against aspergillosis, p.4, September 9–11, 2004, San FranciscoUSA
   Google Scholar
• National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: approved standards. NCCLS document M38-A. Wayne, PA, National Committee for Clinical Laboratory Standards, 2002
   Google Scholar